
Milorgen 75mg/ml Injection
Marketer
RSM Kilitch Pharma Pvt Ltd
Salt Composition
Fosphenytoin (75mg/ml)
Overview Milorgen 75mg/ml Injection
Epileptic seizures are treated with the injectable formulation Milorgen (75mg/ml). This medication reduces excessive, abnormal brain cell activity, thereby controlling seizures. Administration must be overseen by a medical professional; self-injection is strictly prohibited. Complete the prescribed course, even with symptom improvement; premature discontinuation, without consulting your physician, risks life-threatening, continuous seizures. Concomitant use of oral contraceptives may be affected; discuss this with your doctor. Potential side effects include nausea, pruritus, ataxia, and nystagmus. Drowsiness and vertigo are also possible; avoid activities demanding concentration or operating machinery. Injection site reactions, such as erythema or edema, may occur. While most side effects resolve spontaneously, persistent or bothersome symptoms warrant medical attention; strategies to mitigate side effects may be available.
Primary Ingredients of Milorgen 75mg/ml Injection
No text was provided to rewrite.
Uses of Milorgen 75mg/ml Injection
Convulsive disorders
Major Benefits of Milorgen 75mg/ml Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Milorgen 75mg/ml Injection:
- Vomiting
- Sleepiness
- Dizziness
- Itching
- Impaired coordination
- Nystagmus (involuntary eye movement)
- Injection site reactions (pain, swelling, redness)
How to use Milorgen 75mg/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Milorgen 75mg/ml Injection works:
Epileptic seizures are managed by the anticonvulsant Milorgen 75mg/ml Injection, which reduces hyperactive neuronal firing in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Combining Milorgen 75mg/ml Injection and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Administering Milorgen 75mg/ml Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Milorgen 75mg/ml Injection poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, suggesting it's unlikely to harm the infant. However, physician consultation is recommended.
DrivingUNSAFE
Administering Milorgen 75mg/ml Injection may induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Individuals with impaired kidney function should use Milorgen 75mg/ml Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised for patients with pre-existing kidney conditions.
LiverCAUTION
Patients with hepatic impairment should receive Milorgen 75mg/ml Injection with careful monitoring. Dosage modification of Milorgen 75mg/ml Injection may be necessary; physician consultation is recommended.
What if you forget to take Milorgen 75mg/ml Injection :
Should you forget a dose of Milorgen 75mg/ml Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Milorgen 75mg/ml Injection
| Label | Value |
|---|---|
| Chemical Category | Hydantoin-based Compound |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |
| Actions | Anticonvulsant sodium channel blockers |
